Significant muscle loss after stereotactic body radiotherapy predicts worse survival in patients with hepatocellular carcinoma

The relationship between sarcopenia and treatment outcomes, especially in patients with hepatocellular carcinoma (HCC) undergoing stereotactic body radiotherapy (SBRT) has not been well-explored. This study aimed to investigate the effects of sarcopenia on the survival and toxicity after SBRT in pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Jen-Fu, Huang, Wen-Yen, Lo, Cheng-Hsiang, Lee, Meei-Shyuan, Lin, Chun-Shu, Shen, Po-Chien, Dai, Yang-Hong, Wang, Ying-Fu, Chen, Teng-Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9646692/
https://www.ncbi.nlm.nih.gov/pubmed/36352042
http://dx.doi.org/10.1038/s41598-022-21443-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9646692/
https://www.ncbi.nlm.nih.gov/pubmed/36352042
http://dx.doi.org/10.1038/s41598-022-21443-6

Ejemplares similares